Management of NMIBC during BCG shortage and COVID‐19

Trends - Urology & Men's Health Pub Date : 2021-01-01 DOI:10.1002/tre.783

N. Mayor, C. Fankhauser, V. Sangar, H. Mostafid

引用次数: 5

Abstract

Shortages of Bacille Calmette‐Guérin (BCG) have implications for the management of patients with non‐muscle‐invasive bladder cancers. Further complications come as a result of COVID‐19 for which BCG also shows some promising prospects.

查看原文本刊更多论文

卡介苗短缺和COVID - 19期间NMIBC的管理

卡介苗(Bacille Calmette - gusamrin, BCG)的短缺对非肌肉浸润性膀胱癌患者的治疗具有重要意义。COVID - 19可导致进一步的并发症，BCG也显示出一些有希望的前景。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Trends - Urology & Men's Health

自引率

0.00%

发文量